One of the most frustrating things about peripheral neuropathy, for both patients and doctors, is that you may never know with 100% certainty what caused it.
Last time we talked about some of the questions that we commonly get regarding neuropathy and chronic pain. Here are more of our opinions regarding these questions:
- The next thing to understand is that very rarely does drug therapy alone help peripheral neuropathy. For example, some drugs, especially early on, may help calm symptoms—but only to a point. Then virtually every medication has side effects to deal with. Now this is not to say that drugs do not have a place; they certainly do. But when drug-only symptomatic therapy is employed at the expense of leaving out things like proper physical therapy, fitness, and dietary corrections, the net result is the worsening of neuropathy over time.
- One of the most frustrating things about peripheral neuropathy, for both patients and doctors, is that you may never know with 100% certainty what caused your neuropathy. So, the best advice I can give you is to focus upon factors you can correct—like obesity, poor diet, activity levels, et cetera.
If your neuropathy has progressed to the point that significant pain and disability has resulted, usage of medication judiciously is fine, but also make sure that newer treatment methods such as laser & LED therapy, advances in nutrition science, and advanced neurostimulation are all employed.
As frustrating as peripheral neuropathy is, it is imperative that you understand our chief objective is to help you improve your quality of life. No, this is not an easy task. Quite frankly it is enormous.
It becomes even more challenging when there are complications including other illnesses, bad family history or genetics, and so on.
Always remember, we are here to help you. Treating peripheral neuropathy, like most forms of chronic pain, is a work in progress.
It does require due diligence, and significant cooperation between professionals and patients.
I am here to support YOU!
Join the conversation on Facebook!